메뉴 건너뛰기




Volumn 14, Issue 10, 2008, Pages 1406-1412

Cytokine network in rectal mucosa in perianal Crohn's disease: Relations with inflammatory parameters and need for surgery

Author keywords

Cytokines; Perianal Crohn's disease; Prognosis; Surgery

Indexed keywords

AZATHIOPRINE; CYTOKINE; INFLIXIMAB; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESALAZINE; METHOTREXATE; STEROID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

EID: 59749093262     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20486     Document Type: Article
Times cited : (26)

References (37)
  • 1
    • 33845404984 scopus 로고    scopus 로고
    • Fistulizing Crohn's disease
    • Sartor RB, Sandborn WJ, eds, 6th ed. New York: W.B. Saunders;
    • Judge TA, Lichenstein GR. Fistulizing Crohn's disease. In: Sartor RB, Sandborn WJ, eds. Kirsner's Inflammatory Bowel Diseases. 6th ed. New York: W.B. Saunders; 2004:700-716.
    • (2004) Kirsner's Inflammatory Bowel Diseases , pp. 700-716
    • Judge, T.A.1    Lichenstein, G.R.2
  • 2
    • 0030068415 scopus 로고    scopus 로고
    • Perianal Crohn's disease - is it all bad news?
    • McKee RF, Keenan RA. Perianal Crohn's disease - is it all bad news? Dis Colon Rectum. 1996;39:136-142.
    • (1996) Dis Colon Rectum , vol.39 , pp. 136-142
    • McKee, R.F.1    Keenan, R.A.2
  • 3
    • 34548379894 scopus 로고    scopus 로고
    • Perianal Crohn's disease: Classification and clinical evaluation
    • Vermeire S, Van Assche G, Rutgeerts P. Perianal Crohn's disease: classification and clinical evaluation. Dig Liver Dis. 2007;39:959-962.
    • (2007) Dig Liver Dis , vol.39 , pp. 959-962
    • Vermeire, S.1    Van Assche, G.2    Rutgeerts, P.3
  • 4
    • 0031779091 scopus 로고    scopus 로고
    • Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients
    • Lapidus A, Bernell O, Hellers G, et al. Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients. Gastroenterology. 1998;114:1151-1160.
    • (1998) Gastroenterology , vol.114 , pp. 1151-1160
    • Lapidus, A.1    Bernell, O.2    Hellers, G.3
  • 5
    • 0017052951 scopus 로고
    • Anal lesions complicating Crohn disease
    • Homan WP, Tang C, Thorgjarnarson B. Anal lesions complicating Crohn disease. Arch Surg. 1976;111:1333-1335.
    • (1976) Arch Surg , vol.111 , pp. 1333-1335
    • Homan, W.P.1    Tang, C.2    Thorgjarnarson, B.3
  • 6
    • 0028010074 scopus 로고
    • Immune mechanisms in chronic inflammatory bowel disease
    • Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy. 1994;72:135-141.
    • (1994) Ann Allergy , vol.72 , pp. 135-141
    • Braegger, C.P.1    MacDonald, T.T.2
  • 7
    • 16244379546 scopus 로고    scopus 로고
    • Regulatory T cells and intestinal homeostasis
    • Coombes JL, Robinson NJ, Maloy KJ, et al. Regulatory T cells and intestinal homeostasis. Immunol Rev. 2005;204:184-94.
    • (2005) Immunol Rev , vol.204 , pp. 184-194
    • Coombes, J.L.1    Robinson, N.J.2    Maloy, K.J.3
  • 8
    • 32044451548 scopus 로고    scopus 로고
    • Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial
    • Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human antitumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006;130:323-333.
    • (2006) Gastroenterology , vol.130 , pp. 323-333
    • Hanauer, S.B.1    Sandborn, W.J.2    Rutgeerts, P.3
  • 9
    • 8344284998 scopus 로고    scopus 로고
    • Anti-IL-12 Crohn's Disease Study Group. Antiinterleukin-12 antibody for active Crohn's disease
    • Mannon PJ, Fuss IJ, Mayer L, et al. Anti-IL-12 Crohn's Disease Study Group. Antiinterleukin-12 antibody for active Crohn's disease. N Engl J Med. 2004;351:2069-2079.
    • (2004) N Engl J Med , vol.351 , pp. 2069-2079
    • Mannon, P.J.1    Fuss, I.J.2    Mayer, L.3
  • 10
    • 0030954732 scopus 로고    scopus 로고
    • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
    • Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337:1029-1035.
    • (1997) N Engl J Med , vol.337 , pp. 1029-1035
    • Targan, S.R.1    Hanauer, S.B.2    van Deventer, S.J.3
  • 11
    • 19444380965 scopus 로고    scopus 로고
    • Local injection of infliximab for the treatment of perianal Crohn's disease
    • Poggioli G, Laureti S, Pierangeli F, et al. Local injection of infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum. 2005; 48:768-774.
    • (2005) Dis Colon Rectum , vol.48 , pp. 768-774
    • Poggioli, G.1    Laureti, S.2    Pierangeli, F.3
  • 12
    • 0036144887 scopus 로고    scopus 로고
    • Endosonographic evidence of persistence of Crohn's disease associated fistulas after infliximab treatment, irrespective of clinical response
    • Van Bodegraven AA, Sloots CE, Felt-Bersma RJ, et al. Endosonographic evidence of persistence of Crohn's disease associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2002;45:39-45.
    • (2002) Dis Colon Rectum , vol.45 , pp. 39-45
    • Van Bodegraven, A.A.1    Sloots, C.E.2    Felt-Bersma, R.J.3
  • 13
    • 0037282938 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
    • Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol. 2003;98:332-339.
    • (2003) Am J Gastroenterol , vol.98 , pp. 332-339
    • Van Assche, G.1    Vanbeckevoort, D.2    Bielen, D.3
  • 14
    • 34250222082 scopus 로고    scopus 로고
    • Cytokine network in chronic perianal Crohn's disease and indeterminate colitis after colectomy
    • Ruffolo C, Scarpa M, Faggian D, et al. Cytokine network in chronic perianal Crohn's disease and indeterminate colitis after colectomy. J Gastrointest Surg. 2007;11:16-21.
    • (2007) J Gastrointest Surg , vol.11 , pp. 16-21
    • Ruffolo, C.1    Scarpa, M.2    Faggian, D.3
  • 15
    • 0028873006 scopus 로고
    • Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group
    • Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol. 1995;20:27-32.
    • (1995) J Clin Gastroenterol , vol.20 , pp. 27-32
    • Irvine, E.J.1
  • 16
    • 0017227303 scopus 로고
    • Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study
    • Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
    • (1976) Gastroenterology , vol.70 , pp. 439-444
    • Best, W.R.1    Becktel, J.M.2    Singleton, J.W.3
  • 17
    • 0018292706 scopus 로고
    • National Cooperative Crohn's Disease Study: Study design and conduct of the study
    • Winship DH, Summers RW, Singleton JW, et al. National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology. 1979;77:829-842.
    • (1979) Gastroenterology , vol.77 , pp. 829-842
    • Winship, D.H.1    Summers, R.W.2    Singleton, J.W.3
  • 18
    • 4644313604 scopus 로고    scopus 로고
    • C-reactive protein as a marker for inflammatory bowel disease
    • Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10:661-665.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 661-665
    • Vermeire, S.1    Van Assche, G.2    Rutgeerts, P.3
  • 19
    • 0038528406 scopus 로고    scopus 로고
    • The clinical course of fistulating Crohn's disease
    • Bell SJ, Williams AB, Wiesel P, et al. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther. 2003;17:1145-1151.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 1145-1151
    • Bell, S.J.1    Williams, A.B.2    Wiesel, P.3
  • 20
    • 0022621499 scopus 로고
    • Indium 111-granulocyte scanning in the assessment of disease activity in inflammatory bowel disease: A comparison with colonscopy, histology, and fecal indium 111-granulocyte excretion
    • Saverymuttu SH, Camilleri M, Rees H, et al. Indium 111-granulocyte scanning in the assessment of disease activity in inflammatory bowel disease: a comparison with colonscopy, histology, and fecal indium 111-granulocyte excretion. Gastoenterology. 1986;90:1121-1128.
    • (1986) Gastoenterology , vol.90 , pp. 1121-1128
    • Saverymuttu, S.H.1    Camilleri, M.2    Rees, H.3
  • 21
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
    • Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:348-354.
    • (1976) Anal Biochem , vol.72 , pp. 348-354
    • Bradford, M.M.1
  • 22
    • 0030954732 scopus 로고    scopus 로고
    • A short-term study of chimeric monoclonal antibody cA2 to tumour necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
    • Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumour necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med. 1997;337:1029-1035.
    • (1997) N Engl J Med , vol.337 , pp. 1029-1035
    • Targan, S.R.1    Hanauer, S.B.2    van Deventer, S.J.3
  • 23
    • 34347402306 scopus 로고    scopus 로고
    • Adalimumab induction therapy for crohn disease previously treated with infliximab. A randomized trial
    • Sandborn WJ, Rutgeerts P, Enns R, et al. Adalimumab induction therapy for crohn disease previously treated with infliximab. A randomized trial. Ann Intern Med. 2007;146:829-838
    • (2007) Ann Intern Med , vol.146 , pp. 829-838
    • Sandborn, W.J.1    Rutgeerts, P.2    Enns, R.3
  • 24
    • 0030451949 scopus 로고    scopus 로고
    • Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease
    • Reimund JM, Wittersheim C, Dumont S, et al. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut. 1996;39:684-689.
    • (1996) Gut , vol.39 , pp. 684-689
    • Reimund, J.M.1    Wittersheim, C.2    Dumont, S.3
  • 25
    • 0030981088 scopus 로고    scopus 로고
    • Tumour necrosis factor and Crohn's disease
    • Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut. 1997;40:443-448.
    • (1997) Gut , vol.40 , pp. 443-448
    • Van Deventer, S.J.1
  • 26
    • 0037358018 scopus 로고    scopus 로고
    • Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease
    • Agnholt J, Dahlerup JF, Buntzen S, et al. Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Aliment Pharmacol Ther. 2003;17:703-710.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 703-710
    • Agnholt, J.1    Dahlerup, J.F.2    Buntzen, S.3
  • 27
    • 0033179725 scopus 로고    scopus 로고
    • Clinical relevance of serum interleukin-6 in Crohn's disease: Single point measurements, therapy monitoring, and prediction of clinical relapse
    • Reinisch W, Gasche C, Tillinger W, et al. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol. 1999;94:2156-2164.
    • (1999) Am J Gastroenterol , vol.94 , pp. 2156-2164
    • Reinisch, W.1    Gasche, C.2    Tillinger, W.3
  • 28
    • 0033835921 scopus 로고    scopus 로고
    • Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission
    • Van Kemseke C, Belaiche J, Louis E. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis. 2000;15:206-210.
    • (2000) Int J Colorectal Dis , vol.15 , pp. 206-210
    • Van Kemseke, C.1    Belaiche, J.2    Louis, E.3
  • 29
    • 0027451455 scopus 로고
    • Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
    • Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993;94:174-181.
    • (1993) Clin Exp Immunol , vol.94 , pp. 174-181
    • Reinecker, H.C.1    Steffen, M.2    Witthoeft, T.3
  • 30
    • 11144358366 scopus 로고    scopus 로고
    • A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease
    • Ito H, Takazoe M, Fukuda Y, et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology. 2004;126:989-996.
    • (2004) Gastroenterology , vol.126 , pp. 989-996
    • Ito, H.1    Takazoe, M.2    Fukuda, Y.3
  • 31
    • 0028898529 scopus 로고
    • Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
    • Casini-Raggi V, Kam L, Chong YJ, et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol. 1995;154: 2434-2440.
    • (1995) J Immunol , vol.154 , pp. 2434-2440
    • Casini-Raggi, V.1    Kam, L.2    Chong, Y.J.3
  • 32
    • 0036190776 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methitrexate: Results of twenty-four-week, multicenter, randomized,double-blind, placebo-controlled trial
    • Cohen S, Hurd E, Cush J, et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methitrexate: results of twenty-four-week, multicenter, randomized,double-blind, placebo-controlled trial. Arthitis Rheum. 2002;43:614-624.
    • (2002) Arthitis Rheum , vol.43 , pp. 614-624
    • Cohen, S.1    Hurd, E.2    Cush, J.3
  • 33
    • 33646397611 scopus 로고    scopus 로고
    • IL-23 is essential for T cellmediated colitis and promotes inflammation via IL-17 and IL-6
    • Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cellmediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006;116:1310-1316.
    • (2006) J Clin Invest , vol.116 , pp. 1310-1316
    • Yen, D.1    Cheung, J.2    Scheerens, H.3
  • 34
    • 0035072493 scopus 로고    scopus 로고
    • VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation
    • Kanazawa S, Tsunoda T, Onuma E, et al. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol. 2001;96:822-828.
    • (2001) Am J Gastroenterol , vol.96 , pp. 822-828
    • Kanazawa, S.1    Tsunoda, T.2    Onuma, E.3
  • 35
    • 27744485015 scopus 로고    scopus 로고
    • Posttranscriptional regulation of Smad7 in gut of patients with inflammatory bowel disease
    • Monteleone G, Del Vecchio Bianco G, Monteleone I, et al. Posttranscriptional regulation of Smad7 in gut of patients with inflammatory bowel disease. Gastroenterology. 2005;129:1420-1429.
    • (2005) Gastroenterology , vol.129 , pp. 1420-1429
    • Monteleone, G.1    Del Vecchio Bianco, G.2    Monteleone, I.3
  • 36
    • 34548412676 scopus 로고    scopus 로고
    • Surgical therapy of perianal Crohn's disease
    • Singh B, George BD, Mortensen NJ. Surgical therapy of perianal Crohn's disease. Dig Liver Dis. 2007;39:988-992.
    • (2007) Dig Liver Dis , vol.39 , pp. 988-992
    • Singh, B.1    George, B.D.2    Mortensen, N.J.3
  • 37
    • 1842586664 scopus 로고    scopus 로고
    • Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse
    • Yamamoto T, Umegae S, Kitagawa T, et al. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse. Aliment Pharmacol Ther. 2004;19:641-678.
    • (2004) Aliment Pharmacol Ther , vol.19 , pp. 641-678
    • Yamamoto, T.1    Umegae, S.2    Kitagawa, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.